Company intelligence / Profile preview

Lyric Partners

South San Francisco, California, United Stateslullabuddy.com ↗

Ownership: Private
Development stage: Commercial

01

Overview

As of 2015, Lyric Pharmaceuticals was conducting two clinical studies, including a proof-of-concept trial for its lead candidate targeting gastrointestinal disease. No recent clinical results are publicly available.

Therapeutic areas: GastroenterologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

02

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed as of last update.

Beyond the preview

Go deeper on Lyric Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lyric Partners.

Explore the full profile